Erwin Ilegems

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Top Venues

Scientific data

Science translational medicine

Nucleic acids research

Advanced healthcare materials

This page only lists publications with an associated author ORCID identifier.

Publications

Zhenghao Wang, Wei Li, Liping Gou, Ye Zhou, Ge Peng, Jiayi Zhang, Jiaye Liu, Ruoqing Li, Hengfan Ni, Wanli Zhang, Ting Cao, Qi Cao, Hong Su, Yuan-Ping Han, Nanwei Tong, Xianghui Fu, Erwin Ilegems, Yanrong Lu, Per-Olof Berggren, Xiaofeng Zheng, Chengshi Wang
Biodegradable and Antioxidant DNA Hydrogel as a Cytokine Delivery System for Diabetic Wound Healing. Advanced healthcare materials 11 (21) (2022)
Francesco Aulicino, Martin Pelosse, Christine Toelzer, Julien Capin, Erwin Ilegems, Parisa Meysami, Ruth Rollarson, Per-Olof Berggren, Mark Simon Dillingham, Christiane Schaffitzel, Moin A Saleem, Gavin I Welsh, Imre Berger
Highly efficient CRISPR-mediated large DNA docking and multiplexed prime editing using a single baculovirus. Nucleic acids research 50 (13) (2022)
Max Hahn, Christoffer Nord, Pim P van Krieken, Per-Olof Berggren, Erwin Ilegems, Abbas Cheddad, Ulf Ahlgren
Quantitative 3D OPT and LSFM datasets of pancreata from mice with streptozotocin-induced diabetes. Scientific data 9 (1) (2022)
Erwin Ilegems, Galyna Bryzgalova, Jorge C Correia, Burcak Yesildag, Edurne Berra, Jorge L Ruas, Teresa S Pereira, Per-Olof Berggren
HIF-1α inhibitor PX-478 preserves pancreatic β cell function in diabetes. Science translational medicine 14 (638) (2022)
Max Hahn, Pim P van Krieken, Christoffer Nord, Tomas Alanentalo, Federico Morini, Yan Xiong, Maria Eriksson, Jürgen Mayer, Elena Kostromina, Jorge L Ruas, James Sharpe, Teresa Pereira, Per-Olof Berggren, Erwin Ilegems, Ulf Ahlgren
Topologically selective islet vulnerability and self-sustained downregulation of markers for β-cell maturity in streptozotocin-induced diabetes. Communications biology 3 (1) (2020)